Measure Type | High Priority Measure? | Collection Type(s) |
---|---|---|
Outcome | yes | Medicare Part B Claims, MIPS CQM |
Measure Description
Percentage of psoriasis vulgaris patients receiving systemic medication who meet minimal physician-or patient-reported disease activity levels. It is implied that establishment and maintenance of an established minimum level of disease control as measured by physician-and/or patient-reported outcomes will increase patient satisfaction with and adherence to treatment